EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY-NC-ND 4.0

Novel Recruitment, Data Collection, and Safety Reporting Methods in the Era of COVID ‐19: Design of a Post‐Emergency Use Authorization COVID ‐19 Vaccination Safety‐Surveillance Study

Cherise Wong, Katherine Kendrick iD, Laura Webb, Lauren Cohen, M Patricia McAdams, Heather Rubino, Patrick Caubel, Emily O'Brien

Pharmacoepidemiology and Drug Safety · 2026-07 · 35 (7)

DOI: 10.1002/pds.70431 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Pharmacoepidemiology and Drug Safety, online erschienen am 12.07.2026. Verfasst von Cherise Wong und 7 weiteren Autor:innen. Beteiligte Einrichtung: Pfizer Inc., Worldwide Safety, New York, New York, USA. Hauptthemen laut MEDLINE: Adverse Drug Reaction Reporting Systems, COVID-19, COVID-19 Vaccines, Emergency Use Authorization. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Pfizer.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Within one week of the Food and Drug Administration granting the COVID‐19 vaccine Emergency Use Authorization, the HERO‐Together study launched. We describe how the study utilized novel methods for streamlined enrollment and longitudinal data collection to efficiently monitor early and long‐term safety of the COVID‐19 vaccine.

Methods

HERO‐Together is a fully remote, prospective observational cohort study, conducted through an online portal. Participants were recruited from an existing online community of healthcare workers that expanded to family and community members as vaccine eligibility expanded, as well as through marketing and point‐of‐vaccination efforts. Individuals received notifications to submit data at scheduled intervals for two years, and automated reminders prompted participants with missed check‐ins, with centralized call center outreach for non‐responders.

Results

Multiple recruitment approaches were adopted, including direct outreach, national and local media campaigns, downloadable enrollment toolkits (e.g., social media), social media influencer partnerships, and pharmacy referrals. A study population of n = 19, 858 was enrolled within nine months of emergency use authorization, most self‐reporting as white, female, working in healthcare, and all for whom variable survey completion was observed.

Conclusion

Collectively, diverse recruitment strategies, data collection through the online portal, and electronic consent enabled rapid, decentralized enrollment of study participants in order to remotely monitor COVID‐19 vaccine safety during the early days of the pandemic. Trial Registration: EUPAS38671.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Adverse Drug Reaction Reporting SystemsCOVID-19COVID-19 VaccinesEmergency Use AuthorizationProduct Surveillance, PostmarketingAdultFemaleHumansMaleMiddle AgedData CollectionPatient SelectionProspective StudiesUnited StatesVaccination

Stichwörter der Autor:innen

COVID‐19 vaccineobservationalrecruitmentremotesafety

Substanzen

COVID-19 Vaccines

Autor:innen und Institutionen

  • Pfizer Inc., Worldwide Safety, New York, New York, USA.
  • Duke Clinical Research Institute, Durham, North Carolina, USA.
  • Duke University School of Medicine, Durham, North Carolina, USA.

ORCID-Profile: Katherine Kendrick

Förderung

  • Pfizer

Zitieren

APA

Wong, C., Kendrick, K., Webb, L., Cohen, L., McAdams, M. P., Rubino, H., Caubel, P., & O'Brien, E. (2026). Novel Recruitment, Data Collection, and Safety Reporting Methods in the Era of COVID ‐19: Design of a Post‐Emergency Use Authorization COVID ‐19 Vaccination Safety‐Surveillance Study. Pharmacoepidemiology and Drug Safety, 35(7). https://doi.org/10.1002/pds.70431

Vancouver

Wong C, Kendrick K, Webb L, Cohen L, McAdams MP, Rubino H, et al. Novel Recruitment, Data Collection, and Safety Reporting Methods in the Era of COVID ‐19: Design of a Post‐Emergency Use Authorization COVID ‐19 Vaccination Safety‐Surveillance Study. Pharmacoepidemiology and Drug Safety. 2026;35(7). doi:10.1002/pds.70431

BibTeX
@article{Wong2026,
  author = {Wong, Cherise and Kendrick, Katherine and Webb, Laura and Cohen, Lauren and McAdams, M Patricia and Rubino, Heather and Caubel, Patrick and O'Brien, Emily},
  title = {Novel Recruitment, Data Collection, and Safety Reporting Methods in the Era of COVID ‐19: Design of a Post‐Emergency Use Authorization COVID ‐19 Vaccination Safety‐Surveillance Study},
  journal = {Pharmacoepidemiology and Drug Safety},
  year = {2026},
  volume = {35},
  number = {7},
  doi = {10.1002/pds.70431}
}
Kostenlos starten →